Human IgG4-based anti-CD3 x anti-BCMA bispecific monoclonal antibody that binds to CD3 and BCMA

Name: Human IgG4-based anti-CD3 x anti-BCMA bispecific monoclonal antibody that binds to CD3 and BCMA in Multiple Myeloma
Creator: Floatz
License: https://terminal.floatz.ai/terms

Multiple Myeloma

monoclonal_antibodyDormant

26/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 15/ 100
Competitive Position: 59/ 100

Competitive context

498 Active assets in the Multiple Myeloma cohort.

Asset / Sponsor	Phase	Rating
FILGRASTIM Jonsson Comprehensive Cancer Center	Phase 4	BBB
Inno-206 University of Arkansas	Phase 3	BBB
Hyaluronidase fihj Massachusetts General Hospital	Phase 4	BBB
Busulphan M.D. Anderson Cancer Center	Phase 4	BBB
Filanesib PETHEMA Foundation	Phase 2	BBB

View all 50 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →